ESPR
Esperion Therapeutics Inc
Price:  
2.51 
USD
Volume:  
3,264,925.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ESPR Relative Valuation

-1096.4%
Upside

As of 2024-03-01, the Relative Valuation of Esperion Therapeutics Inc (ESPR) is (25.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.51 USD, the upside of Esperion Therapeutics Inc based on Relative Valuation is -1096.4%.

The range of the Relative Valuation is (20.84) - (24.89) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 17.1x - 25.8x 21.8x
Forward P/E multiples 16.6x - 20.4x 19.2x
Fair Price (20.84) - (24.89) (25.01)
Upside -930.1% - -1091.5% -1096.4%
2.51 USD
Stock Price
(25.01) USD
Fair Price

ESPR Relative Valuation - Historical P/E Data

Date P/E
2024-03-01 -2.09
2024-02-29 -2.06
2024-02-28 -2.11
2024-02-27 -2.38
2024-02-26 -2.16
2024-02-23 -2.14
2024-02-22 -2.16
2024-02-21 -2.14
2024-02-20 -2.20
2024-02-16 -2.21
2024-02-15 -2.18
2024-02-14 -2.14
2024-02-13 -2.08
2024-02-12 -2.13
2024-02-09 -2.11
2024-02-08 -2.11
2024-02-07 -2.16
2024-02-06 -2.11
2024-02-05 -1.95
2024-02-02 -1.80
2024-02-01 -1.70
2024-01-31 -1.75
2024-01-30 -1.66
2024-01-29 -1.78
2024-01-26 -1.75
2024-01-25 -1.71
2024-01-24 -1.66
2024-01-23 -1.75
2024-01-22 -1.76
2024-01-19 -1.66
2024-01-18 -1.76
2024-01-17 -2.11
2024-01-16 -2.30
2024-01-12 -2.48
2024-01-11 -2.46
2024-01-10 -2.25
2024-01-09 -2.29
2024-01-08 -2.30
2024-01-05 -2.09
2024-01-04 -1.89
2024-01-03 -1.89
2024-01-02 -2.39
2023-12-29 -2.45
2023-12-28 -2.52
2023-12-27 -2.32
2023-12-26 -2.11
2023-12-22 -1.93
2023-12-21 -1.91
2023-12-20 -1.86
2023-12-19 -1.92